Amyloid PET

DIAGNOSTIC_TEST5 trials

Sponsors

Okita Kyoji, National Taiwan University Hospital, University of Pennsylvania

Conditions

Alzheimer DiseaseAlzheimer's, cognitive impairmentCerebral Amyloid AngiopathyIntracranial HemorrhagesTauopathiesVascular Cognitive Impairment

Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503

RecruitingNCT06303921

University of PennsylvaniaTauopathies

Start: 2024-02-16End: 2029-02-28Target: 70Updated: 2025-04-22

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

RecruitingNCT06932809

University of PennsylvaniaTauopathies

Start: 2025-05-09End: 2030-04-30Target: 90Updated: 2025-12-23

Phase 3

Application of Amyloid PET in Cerebral Amyloid Angiopathy

CompletedNCT03542656

National Taiwan University HospitalAlzheimer Disease, Cerebral Amyloid Angiopathy, Intracranial Hemorrhages

Start: 2014-09-11End: 2018-03-22Updated: 2019-05-30

Multimodal Biomarkers for Diagnosis and Prognosis in VCI

National Taiwan University HospitalAlzheimer Disease, Vascular Cognitive Impairment

Start: 2020-09-03End: 2023-07-31Target: 120Updated: 2020-10-27

Unknown Phase

Florbetapir diagnostic impact study

Active, not recruitingJPRN-jRCTs031180446

Okita KyojiAlzheimer's, cognitive impairment

Start: 2019-05-23Target: 120Updated: 2025-07-18